Pharmacology |
Toxins |
Unfinished |
2006-12-13 |
stuschroff |
8 |
0 |
edit |
|
Drug Metabolism |
Phase I |
Unfinished |
2006-12-19 |
stuschroff |
5 |
0 |
edit |
|
Drug Metabolism |
Phase II |
Unfinished |
2006-12-19 |
stuschroff |
3 |
0 |
edit |
|
Age& Drug Metabolism |
Age& Drug Metabolism |
Unfinished |
2006-12-13 |
stuschroff |
3 |
0 |
edit |
|
Drug Metabolism |
Renal insufficiency and hepatic dysfunction |
Unfinished |
2006-12-13 |
stuschroff |
2 |
0 |
edit |
|
Drug Interactions |
Drug Interactions |
Unfinished |
2006-12-13 |
stuschroff |
10 |
0 |
edit |
|
Microbiology |
Eukaryotes vs. Prokaryotes |
Unfinished |
2006-11-25 |
stuschroff |
24 |
0 |
edit |
|
Microbiology |
Classification of bacteria |
Unfinished |
2006-11-25 |
stuschroff |
3 |
0 |
edit |
|
Microbiology |
Bacteria cell structure |
Unfinished |
2006-11-25 |
stuschroff |
30 |
0 |
edit |
|
BacteriaPathogenesis |
Stack #57017 |
Unfinished |
2006-11-25 |
stuschroff |
23 |
0 |
edit |
|
Gram Positive Cocci |
Stack #57025 |
Unfinished |
2015-08-02 |
stuschroff |
71 |
0 |
edit |
|
Gram + Bacilli |
Part I and II |
Unfinished |
2006-11-27 |
stuschroff |
70 |
0 |
edit |
|
Gram + bacilli |
Clinically Important INDIGENOUS bacteria (not sure it's worth it) |
Unfinished |
2006-12-18 |
stuschroff |
25 |
0 |
edit |
|
Anaerobic Bacteria |
Intro to Anaerobic bacteria of medical relevance |
Unfinished |
2006-11-27 |
stuschroff |
37 |
0 |
edit |
|
Neisseria |
Neisseria |
Unfinished |
2006-11-28 |
stuschroff |
44 |
0 |
edit |
|
Diagnostic Methods |
Stack #57510 |
Unfinished |
2006-11-29 |
stuschroff |
7 |
0 |
edit |
|
Mycobacteria |
Introduction |
Unfinished |
2006-11-29 |
stuschroff |
68 |
0 |
edit |
|
Intracell bacteria |
Introduction |
Unfinished |
2006-11-29 |
stuschroff |
66 |
0 |
edit |
|
Antibiotic Resistanc |
Antibiotic Resistanc |
Unfinished |
2006-11-30 |
stuschroff |
60 |
0 |
edit |
|
Spirochetes |
Spirochetes |
Unfinished |
2006-12-04 |
stuschroff |
84 |
0 |
edit |
|
Microbiology |
Antimicrobial Agents |
Unfinished |
2006-12-04 |
stuschroff |
105 |
0 |
edit |
|
Bacterial Resistance |
to single and multpile antibiotics: bacterial plasmids |
Unfinished |
2006-12-05 |
stuschroff |
78 |
0 |
edit |
|
Viruses |
Structure and Classification |
Unfinished |
2006-12-05 |
stuschroff |
80 |
0 |
edit |
|
RNA Viruses |
Class III and IV (postive stranded and double stranded genomes) |
Unfinished |
2006-12-06 |
stuschroff |
85 |
0 |
edit |
|
Retroviruses |
Retroviruses |
Unfinished |
2006-12-07 |
stuschroff |
64 |
0 |
edit |
|
DNA Viruses |
Adenovirus and Parvovirus |
Unfinished |
2006-12-07 |
stuschroff |
85 |
0 |
edit |
|
DNA Viruses |
Herpes Viruses |
Unfinished |
2006-12-07 |
stuschroff |
124 |
0 |
edit |
|
Antibiotics |
Adverse Effects Caused by Antibiotics |
Unfinished |
2006-12-07 |
stuschroff |
16 |
0 |
edit |
|
Antibiotics |
CSF penetration of antibiotics(only supportive info to treat meningeal infection |
Unfinished |
2006-12-07 |
stuschroff |
19 |
0 |
edit |
|
Antibiotics |
Mechanisms, Pharmacokinetics, and Adverse Effects |
Unfinished |
2006-12-13 |
stuschroff |
3 |
0 |
edit |
|
Antibiotics |
Cell Wall Synthesis Inhibitors and their clinical uses |
Unfinished |
2006-12-08 |
stuschroff |
15 |
0 |
edit |
|
Antibiotics |
Protein synthesis inhibitors |
Unfinished |
2006-12-08 |
stuschroff |
4 |
0 |
edit |
|
Antibiotics |
Miscellaneous antibacterial drugs |
Unfinished |
2006-12-22 |
stuschroff |
7 |
0 |
edit |
|
Antibiotics |
Some Clinical Uses of Antibiotics |
Unfinished |
2006-12-09 |
stuschroff |
10 |
0 |
edit |
|
Antibiotics |
Drug Interactions |
Unfinished |
2006-12-22 |
stuschroff |
7 |
0 |
edit |
|
Antibiotics |
Contraindications |
Unfinished |
2006-12-09 |
stuschroff |
7 |
0 |
edit |
|
Antiviral Drugs |
Antiviral Drugs |
Unfinished |
2006-12-09 |
stuschroff |
6 |
0 |
edit |
|
Antiviral Drugs |
Therapy for various viral infections |
Unfinished |
2006-12-09 |
stuschroff |
9 |
0 |
edit |
|
Antiamebic Drugs |
Antiamebic Drugs |
Unfinished |
2006-12-09 |
stuschroff |
5 |
0 |
edit |
|
Antiamebic Drugs |
Treatment of Amebiasis |
Unfinished |
2006-12-21 |
stuschroff |
3 |
0 |
edit |
|
Pharmacogenetics |
Pharmacogenetics |
Unfinished |
2006-12-09 |
stuschroff |
5 |
0 |
edit |
|
Anticancer Drugs |
Alkylating agents (bind to N-7 residue in DNA) |
Unfinished |
2006-12-09 |
stuschroff |
9 |
0 |
edit |
|
Anticancer Drugs |
Antimetabolites (inhibit syn of DNA precursors and sub. normal bases in RNA&DNA |
Unfinished |
2006-12-21 |
stuschroff |
7 |
0 |
edit |
|
Anticancer Drugs |
Site of Action in the cell cycle |
Unfinished |
2006-12-21 |
stuschroff |
15 |
0 |
edit |
|
Anticancer Drugs |
Natural Products and Hormones |
Unfinished |
2006-12-21 |
stuschroff |
11 |
0 |
edit |
|
Anticancer Drugs |
Unique, dose-limiting, and life-threatening side effects |
Unfinished |
2006-12-09 |
stuschroff |
7 |
0 |
edit |
|
Pharmacology |
Drug Exceptions |
Unfinished |
2006-12-09 |
stuschroff |
2 |
0 |
edit |
|
Pharmacology |
Examples of multidrug regimens for anticancer therapy |
Unfinished |
2006-12-09 |
stuschroff |
5 |
0 |
edit |
|
Pharmacology |
Clinical Uses of anticancer drugs |
Unfinished |
2006-12-09 |
stuschroff |
16 |
0 |
edit |
|
Pharmacology |
Hormonal Therapy following surgery and/or radiation to prevent recurrence |
Unfinished |
2006-12-09 |
stuschroff |
10 |
0 |
edit |
|
Pharmacology |
Methods of Drug Resistance by Anticancer drugs |
Unfinished |
2006-12-21 |
stuschroff |
6 |
0 |
edit |
|
Pharmacology |
Drug interactions of anticancer drugs |
Unfinished |
2006-12-09 |
stuschroff |
5 |
0 |
edit |
|
RNA Viruses |
Negative stranded genomes (all helical and enveloped) |
Unfinished |
2006-12-09 |
stuschroff |
61 |
0 |
edit |
|
Viral |
Exanthematous Diseases |
Unfinished |
2006-12-10 |
stuschroff |
66 |
0 |
edit |
|
Viral Pathogenesis |
Viral Pathogenesis |
Unfinished |
2006-12-10 |
stuschroff |
78 |
0 |
edit |
|
Parasitology |
Introduction to Parasites |
Unfinished |
2006-12-10 |
stuschroff |
65 |
0 |
edit |
|
Parasitology 2 |
Schistosomiasis |
Unfinished |
2006-12-10 |
stuschroff |
89 |
2 |
edit |
|
Pharmacology |
Biochemistry of Eicosanoids |
Unfinished |
2006-12-22 |
stuschroff |
20 |
0 |
edit |
|
Pharmacology |
Eicosanoids and Plateley Activating Factor |
Unfinished |
2006-12-10 |
stuschroff |
75 |
0 |
edit |
|
Pharmacology |
Biogenic Amines (class of autocoid) |
Unfinished |
2006-12-11 |
stuschroff |
136 |
0 |
edit |
|
Pharmacology |
Vasoactive Peptides and NO |
Unfinished |
2006-12-12 |
stuschroff |
75 |
0 |
edit |
|
Mycology |
Introduction to Mycology |
Unfinished |
2006-12-12 |
stuschroff |
54 |
0 |
edit |
|
Mycology |
Comparison of Primary and Opportunistic Fungal Pathogens |
Unfinished |
2006-12-12 |
stuschroff |
41 |
0 |
edit |
|
Nucleotide Metabolis |
P and T |
Unfinished |
2006-12-13 |
stuschroff |
36 |
0 |
edit |
|
Pharmacology |
Contraindications |
Unfinished |
2006-12-13 |
stuschroff |
11 |
0 |
edit |
|
Pharmacology |
Antifungal Drugs |
Unfinished |
2006-12-13 |
stuschroff |
5 |
0 |
edit |
|
Pharmacology |
Therapy for Mycoses |
Unfinished |
2006-12-21 |
stuschroff |
10 |
0 |
edit |
|
Heme |
Normal Hematologic Values |
Unfinished |
2007-01-11 |
stuschroff |
36 |
0 |
edit |
|